FDA Device Intelligence
HomeDRG Instruments Gesellschaft mit beschränkter Haftung › Proteinase-3 IgG ELISA

Proteinase-3 IgG ELISA

DRG Instruments Gesellschaft mit beschränkter Haftung · Model EIA-2778 · UDI-DI 04048474027785

MOB Prescription
1
510(k) clearances
3
Adverse events (1 deaths)
1
Recalls
25
Facilities

Description

The DRG ELISA Proteinase-3 (PR-3) Test System is intended for the qualitative and semi-quantitative detection of IgG-class antibody to proteninase-3 in human serum. The test is intended to be used as an aid in the diagnosis of various autoimmune vasculitic disorders characterized by elevated levels of anti-neutrophil cytoplasmic antibodies (ANCA).

Recalls

DateFirmReason
2023-05-24Phadia AbComplaints that specific samples produced false positive EliA GBM results. A positive signal was present when these samples were tested for coating-solution reactivity using EliA w

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.